Evidence map›Paper›PMID 35203350›Full record

ArticleCells2022

Mitofusin-2 Negatively Regulates Melanogenesis by Modulating Mitochondrial ROS Generation.

Jyoti Tanwar, Suman Saurav, Reelina Basu, Jaya Bharti Singh, Anshu Priya, Maitreyee Dutta, Uma Santhanam, Manoj Joshi, Stephen Madison, Archana Singh and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. 2-Methoxystypandrone fromAntioxidants (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Mitochondrial bioenergetics and networks in melanoma: an update.Apoptosis : an international journal on programmed cell death · 2025
    Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. A Peptide HEPFYGNEGALR fromMolecules (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Jyoti TanwarCSIR-Institute of Genomics and Integrative Biology (IGIB), New Delhi 110025, India.ORCID 0000-0001-9610-6405
Suman SauravLaboratory of Calciomics and Systemic Pathophysiology, Regional Centre for Biotechnology (RCB), Faridabad 121001, Delhi-NCR, India.
Reelina BasuCSIR-Institute of Genomics and Integrative Biology (IGIB), New Delhi 110025, India.ORCID 0000-0001-6589-2618
Jaya Bharti SinghLaboratory of Calciomics and Systemic Pathophysiology, Regional Centre for Biotechnology (RCB), Faridabad 121001, Delhi-NCR, India.
Anshu PriyaCSIR-Institute of Genomics and Integrative Biology (IGIB), New Delhi 110025, India.
Maitreyee DuttaUnilever R and D, Bangalore 560066, India.
Uma SanthanamUnilever R and D, Bangalore 560066, India.
Manoj JoshiUnilever R and D, Bangalore 560066, India.
Stephen MadisonUnilever R and D, Bangalore 560066, India.
Archana SinghCSIR-Institute of Genomics and Integrative Biology (IGIB), New Delhi 110025, India.
Nirmala NairUnilever R and D, Bangalore 560066, India.
Rajesh S GokhaleCSIR-Institute of Genomics and Integrative Biology (IGIB), New Delhi 110025, India.
Rajender K MotianiLaboratory of Calciomics and Systemic Pathophysiology, Regional Centre for Biotechnology (RCB), Faridabad 121001, Delhi-NCR, India.ORCID 0000-0002-8971-9008
Institute of Genomics and Integrative Biology · INUnilever (India) · INRegional Centre for Biotechnology · IN

Funding

DBT-Wellcome Trust India Alliance IA/I/19/2/504651Science and Engineering Research Board SRG/2019/000495Unilever R and D, India CLP0027Wellcome Trust/DBT India Alliance IA/I/19/2/504651
6 · The paper itself

Abstract

Inter-organellar communication is emerging as one of the most crucial regulators of cellular physiology. One of the key regulators of inter-organellar communication is Mitofusin-2 (MFN2). MFN2 is also involved in mediating mitochondrial fusion-fission dynamics. Further, it facilitates mitochondrial crosstalk with the endoplasmic reticulum, lysosomes and melanosomes, which are lysosome-related organelles specialized in melanin synthesis within melanocytes. However, the role of MFN2 in regulating melanocyte-specific cellular function, i.e., melanogenesis, remains poorly understood. Here, using a B16 mouse melanoma cell line and primary human melanocytes, we report that MFN2 negatively regulates melanogenesis. Both the transient and stable knockdown of MFN2 leads to enhanced melanogenesis, which is associated with an increase in the number of mature (stage III and IV) melanosomes and the augmented expression of key melanogenic enzymes. Further, the ectopic expression of MFN2 in MFN2-silenced cells leads to the complete rescue of the phenotype at the cellular and molecular levels. Mechanistically, MFN2-silencing elevates mitochondrial reactive-oxygen-species (ROS) levels which in turn increases melanogenesis. ROS quenching with the antioxidant N-acetyl cysteine (NAC) reverses the MFN2-knockdown-mediated increase in melanogenesis. Moreover, MFN2 expression is significantly lower in the darkly pigmented primary human melanocytes in comparison to lightly pigmented melanocytes, highlighting a potential contribution of lower MFN2 levels to higher physiological pigmentation. Taken together, our work establishes MFN2 as a novel negative regulator of melanogenesis.

Indexed as

Melanoma, ExperimentalMelanosomesAnimalsMelaninsMelanocytesMiceMitochondriaReactive Oxygen SpeciesMelaninsReactive Oxygen SpeciesmelanogenesismelanosomeMFN2mitochondriareactive oxygen species

Identifiers

PMID35203350
PMCPMC8869806
OpenAlexW4212834387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.